Cyclin-dependent kinases such as Cdk4 are involved in the control of cell c
ycle progression, and misregulation of Cdk4 has been implicated in many typ
es of cancers. In the present study, we report the development of a novel h
omogeneous assay using an affinity peptide-tagging technology for rapidly d
iscovering Cdk4 inhibitors. The DNA sequence encoding a streptavidin recogn
ition motif, or StrepTag (AWRHPQFGG), was cloned and expressed at the C-ter
minus of a fusion protein of a 152-amino acid hyperphosphorylation domain (
Rb152) of the retinoblastoma protein (Rb) linked to GST at the N-terminus.
This affinity peptide-tagged protein (GST-Rb152-StrepTag), which contains t
he two known phosphorylation sites of Rb, specifically phosphorylated by Cd
k4 in vivo, was used as a substrate in the current in vitro kinase assay. A
fter phosphorylation, scintillation proximity assay (SPA) scintillant beads
coated with streptavidin were added. Radiolabeled GST-Rb152-StrepTag was b
rought in close proximity to the SPA scintillant beads through the interact
ion between StrepTag and streptavidin, resulting in the emission of light f
rom beads. By applying the affinity peptide-tagging technology, we have eli
minated the separation and wash steps which are normally required in a radi
oactive filtration assay. Therefore, this homogeneous method is simple, rob
ust; and highly amenable to high-throughput screening of Cdk4-specific inhi
bitors. Furthermore, the affinity peptide tagging technique reported here i
s a simple, generic method that can be applied to many recombinant proteins
for the development of kinase and protein-protein interaction assays.